Response Genetics has launched its Non-Small Cell Lung Cancer Profile test that combines a FISH- and RNA expression-based test for EGFR, ALK, and ROS1, with next-generation sequencing of a broader gene panel. Initially, the FISH and expression tests are offered for EGFR, ALK, and ROS1 — genes recommended by the National Comprehensive Cancer Network. That test is performed within five to seven business days and if negative, the next-gen sequencing panel is run.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.